Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Hormone Receptor Positive Tumor
Interventions: DRUG: Tamoxifen Citrate
Sponsor: British Columbia Cancer Agency
Collaborators: Canadian Cancer Society (CCS)|NanoString Technologies, Inc.